7X6K
SARS-CoV-2 3CL protease (3CLpro) in complex with compound 3w
7X6K の概要
| エントリーDOI | 10.2210/pdb7x6k/pdb |
| 分子名称 | 3C-like proteinase, 1H-indole-2-carbaldehyde (3 entities in total) |
| 機能のキーワード | viral protein-inhibitor complex, viral protein/inhibitor |
| 由来する生物種 | Severe acute respiratory syndrome coronavirus 2 |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 33970.71 |
| 構造登録者 | |
| 主引用文献 | Pillaiyar, T.,Flury, P.,Kruger, N.,Su, H.,Schakel, L.,Barbosa Da Silva, E.,Eppler, O.,Kronenberger, T.,Nie, T.,Luedtke, S.,Rocha, C.,Sylvester, K.,Petry, M.R.I.,McKerrow, J.H.,Poso, A.,Pohlmann, S.,Gutschow, M.,O'Donoghue, A.J.,Xu, Y.,Muller, C.E.,Laufer, S.A. Small-Molecule Thioesters as SARS-CoV-2 Main Protease Inhibitors: Enzyme Inhibition, Structure-Activity Relationships, Antiviral Activity, and X-ray Structure Determination. J.Med.Chem., 65:9376-9395, 2022 Cited by PubMed Abstract: The main protease (M, 3CL) of SARS-CoV-2 is an attractive target in coronaviruses because of its crucial involvement in viral replication and transcription. Here, we report on the design, synthesis, and structure-activity relationships of novel small-molecule thioesters as SARS-CoV-2 M inhibitors. Compounds and exhibited excellent SARS-CoV-2 M inhibition with / of 58,700 M s ( = 0.0141 μM) and 27,200 M s ( = 0.0332 μM), respectively. In Calu-3 and Vero76 cells, compounds , , , , , and displayed antiviral activity in the nanomolar range without host cell toxicity. Co-crystallization of and with SARS-CoV-2 M was accomplished, and the X-ray structures showed covalent binding with the catalytic Cys145 residue of the protease. The potent SARS-CoV-2 Mpro inhibitors also inhibited the M of other beta-coronaviruses, including SARS-CoV-1 and MERS-CoV, indicating that they might be useful to treat a broader range of coronaviral infections. PubMed: 35709506DOI: 10.1021/acs.jmedchem.2c00636 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.34 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






